July 24 Financial Quick Takes: $500M for Seattle Genetics; plus X-Vax, TScan, Alexion and more
Seattle Genetics raises $500M follow-on
Seattle Genetics Inc. (NASDAQ:SGEN) raised $500 million late Tuesday through the sale of 7.1 million shares at $70. The price is an 8% discount to the company's close of $75.95 on Tuesday when it proposed the offering. The funds will support commercialization and label expansion of Adcetris brentuximab vedotin, which the company markets for non-Hodgkin lymphoma.
X-Vax raises $56M series A
X-Vax Technology Inc. (Jupiter, Fla.) raised $56 million in an upsized series A round that saw participation by Johnson & Johnson Innovation - JJDC Inc., Adjuvant Capital, Serum Institute of India, Alexandria Venture Investments and Founders Fund. The company will use the funding to advance its lead herpes vaccine delta gD-2 into Phase I testing...